ANTIBIOTIC PREVENTION OF INTERCURRENT INFECTIONS IN DIABETES MELLITUS
Authors: L V McVAY, D H SPRUNT, T N STERN, F E TATUM, A LIPSCOMB
Journal: Annals of Internal Medicine (1954)

Article1 February 1954ANTIBIOTIC PREVENTION OF INTERCURRENT INFECTIONS IN DIABETES MELLITUSLEON V. MCVAY JR., M.D., DOUGLAS H. SPRUNT, M.D., F.A.C.P., THOMAS N. STERN, M.D., FREDERICK E. TATUM, M.D., ALYS LIPSCOMB, M.D.LEON V. MCVAY JR., M.D.Search for more papers by this author, DOUGLAS H. SPRUNT, M.D., F.A.C.P.Search for more papers by this author, THOMAS N. STERN, M.D.Search for more papers by this author, FREDERICK E. TATUM, M.D.Search for more papers by this author, ALYS LIPSCOMB, M.D.Search for more papers by this authorAuthor, Article, and Disclosure Informationhttps://doi.org/10.7326/0003-4819-40-2-269 SectionsAboutPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail ExcerptWith the steadily increasing number of elderly individuals in the general population, a greater interest in the diseases characteristic of later life has developed.1 Outstanding among these conditions are cardiovascular disease, malignancy and diabetes mellitus. It has been estimated that almost 4,000,000 persons now living in this country will eventually have diabetes.2 Furthermore, the outlook for the next few decades is such that the incidence of this metabolic derangement may be expected to increase twice as fast as the total population. This, of course, implies that diabetes mellitus will be an even greater medical problem in the future.The important...Bibliography1. Pepper OH: Geriatrics: past, present and future, Am. J. M. Sc. 223: 589, 1952. CrossrefMedlineGoogle Scholar2. SpiegelmanMarks MHH: Age and sex variations in the prevalence and onset of diabetes mellitus, Am. J. Pub. Health 36: 26, 1946. CrossrefGoogle Scholar3. JoslinRootWhiteMarbleBailey EPHFPACC: The treatment of diabetes mellitus, 1947, Lea and Febiger Co., Philadelphia. Google Scholar4. HarrisonBaily JHOT: Significance of necrotizing pyelonephritis in diabetes mellitus, J. A. M. A. 118: 15, 1942. CrossrefGoogle Scholar5. BaldwinRoot ADHF: Infections of the upper urinary tract in the diabetic patient, New England J. Med. 223: 244, 1940. CrossrefGoogle Scholar6. RobbinsTucker SLAW: The cause of death in diabetes, New England J. Med. 231: 865, 1944. CrossrefGoogle Scholar7. WilsonRootMarble JLHFA: Prevention of degenerative vascular lesions in young patients by control of diabetes, Am. J. M. Sc. 221: 479, 1951. CrossrefMedlineGoogle Scholar8. RootStoryCortesi HFRDJB: Diabetic coma versus diabetic nephropathy, New England J. Med. 245: 765, 1951. CrossrefMedlineGoogle Scholar9. SilbersteinPaugh JSJT: Necrotizing papillitis, Ann. Int. Med. 38: 689, 1953. LinkGoogle Scholar10. Mandel EE: Editorial: Renal medullary necrosis, Arch. Int. Med. 91: 417, 1953. CrossrefGoogle Scholar11. BreeseBellowsFischelKutnerMassellRammelkampSchlesinger BBMTEEABFCHER: Statements of American Heart Association Council on Rheumatic Fever and Congenital Heart Disease: Prevention of rheumatic fever, J. A. M. A. 151: 141, 1953. MedlineGoogle Scholar12. McVayStern LVTN: An effective and economical method for the treatment of acute nontuberculous bacterial pneumonia, Antibiotics and Chemotherapy 2: 215 1952. Google Scholar13. CollinsPaineFinland HSTFM: Clinical studies with Aureomycin, Ann. New York Acad. Sc. 51: 175, 1948. CrossrefGoogle Scholar14. McVayCarroll LVDS: Aureomycin in the treatment of systemic North American blastomycosis, Am. J. Med. 12: 289, 1952. CrossrefMedlineGoogle Scholar15. McVaySprunt LVDH: Bacteroides infections, Ann. Int. Med. 36: 56, 1952. LinkGoogle Scholar16. McVaySprunt LVDH: A long term evaluation of Aureomycin in the treatment of amebiasis, South. M. J. 45: 183, 1952. CrossrefMedlineGoogle Scholar17. McVayGuthrieSprunt LVFDH: Aureomycin in the treatment of actinomycosis, New England J. Med. 245: 91, 1951. CrossrefMedlineGoogle Scholar18. McVaySprunt LVDH: A study of moniliasis in Aureomycin therapy, Proc. Soc. Exper. Biol. and Med. 78: 759, 1951. CrossrefMedlineGoogle Scholar19. PriceRandallWelch CWWAH: Bacteriological studies of Aureomycin, Ann. New York Acad. Sc. 51: 211, 1948. CrossrefMedlineGoogle Scholar20. BlissTodd EAHP: A comparison of eight antibiotics in vivo and in vitro , J. Bact. 58: 61, 1949. CrossrefMedlineGoogle Scholar21. McVay LV: Antibiotic prophylaxis in chronic congestive failure, in press. Google Scholar22. McVaySprunt LVDH: Antibiotic prophylaxis in chronic respiratory diseases, in press. Google Scholar23. Duncan GG: Diabetic coma—a therapeutic problem, Ann. Int Med. 37: 1188, 1952. LinkGoogle Scholar24. McVaySprunt LVDH: Aureomycin in the prophylaxis of rheumatic fever, New England J. Med., in press. Google Scholar This content is PDF only. To continue reading please click on the PDF icon. Author, Article, and Disclosure InformationAffiliations: *Received for publication May 29, 1953.From the Divisions of Medicine, Pathology and Bacteriology of the University of Tennessee College of Medicine and the John Gaston Hospital, Memphis, Tennessee. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byThe susceptible hostIV. Protection against infection insusceptible individualsFEVER IN MALIGNANT NEOPLASTIC DISEASE: A CONTROLLED STUDY OF TETRACYCLINE THERAPY*DANE R. BOGGS, M.D., EMIL FREI III, M.D., CHARLES H. ZIERDT, M.S.THE CHEMOPROPHYLAXIS OF INFECTION*LOUIS WEINSTEIN, Ph.D., M.D., F.A.C.P. 1 February 1954Volume 40, Issue 2Page: 269-284KeywordsAntibioticsBacteriologyCardiovascular diseasesDiabetes mellitusDiabetes preventionElderlyForecastingHospital medicine ePublished: 1 December 2008 Issue Published: 1 February 1954 PDF downloadLoading ...